All my son wanted was his prescription – the next day he died

It all came crumbling down in 2021 (Picture: w8media) Hopping out of the front passenger seat, I walked around the car to give my son, Charlie, a hug goodbye. It was June 26, 2021 and my husband, Richard, and I had just dropped him home. Charlie...

Upperton Pharma Solutions wins Business Expansion Award

Upperton Pharma Solutions, a Nottingham-based pharmaceutical contract development and manufacturing organisation (CDMO), is the winner of the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology...

Pharma could face up to 200% tariffs: Trump

New Delhi: Turning up the tariffs threat on the pharmaceuticals industry–so far exempted from such restrictions–the US president Donald Trump said the industry may soon face a very high rate as much as 200 per cent. Speaking to reports at the...

LeucineOS: India’s Unified Digital Core for Pharma 4.0

A closer look at where the pharmaceutical industry stands on Pharma 4.0, the barriers toconnected digital ecosystems, and how Leucine’s unified software platform is enabling smarter, connected operations. "Indian generics can no longer afford...

NeuroVoices: Kumar Budur, MD, MS, on BP1.15205 as a Next-Gen Therapy for Narcolepsy

Narcolepsy is a rare, chronic, neurological disease of sleep-wake state instability that impacts approximately 170,000 Americans and is primarily characterized by excessive daytime sleepiness and cataplexy, along with other manifestations of REM...

New radiopharma Actithera emerges with $75.5m in financing

A new player in radioligand therapies (RLTs), Norway and US-based Actithera, has arrived on the scene with $75.5 million in first-round financing and a lead asset for cancer in preclinical development. The proceeds will be used to move the RLT –...

Lupin signs $50 million licensing deal with Zentiva to commercialise Certolizumab Pegol across global markets

Pharma major Lupin Ltd on Wednesday said it has inked a license and supply pact for commercialisation of its biosimilar 'Certolizumab Pegol' across multiple global markets with the Zentiva Group, entailing milestone receivables of up to USD 50...

As its cancer vaccine moves through the clinic, Transgene sets sights on manufacturing

Welcome to First 90 Days, a series dedicated to examining how pharma executives and other leaders are planning for success in their new roles. Today, we’re speaking to Simone Steiner, Transgene’s new chief technology officer, about how the company...

Is MSD preparing a $10bn deal to buy Verona?

The pace of M&A in the pharma sector this year looks set to accelerate even further, with reports emerging this morning that MSD is readying a takeover offer for respiratory medicine specialist Verona Pharma. According to the Financial Times, MSD...

MTaI raises concerns over Maharashtra’s decision to allow homeopathy practitioners to prescribe allopathic medicines

New Delhi: The Maharashtra Medical Council's (MMC) recent notification allowing practitioners of homeopathy to prescribe modern medicines after a six-month modern pharmacology course (CCMP), and the FDA's directive to chemists, have understandably...

Merck to buy respiratory drugmaker Verona Pharma for $10B

Georgina Energy targets gas growth after audit delay

About Stephen Davidson For nearly 10 years, Steve's top priority has been helping public companies communicate with shareholders in both Canada and the United States. He spent 7.5 years at Cambridge House International, eventually becoming Vice...

Novo Nordisk files high-dose Wegovy in EU

Novo Nordisk has moved quickly to file for approval of a new, higher-dose version of its obesity therapy Wegovy as it tries to fend off a growing challenge in the market from arch-rival Eli Lilly. Data from two phase 2b trials of the 7.2mg...

AstraZeneca’s Alexion inks AAV capsid deal with JCR Pharma

Arrowhead doses first patient in Phase III trial of zodasiran for HoFH treatment

Arrowhead Pharmaceuticals has dosed the first participant in the randomised, multicentre Phase III YOSEMITE trial of the investigational RNA interference (RNAi) therapeutic, zodasiran, under development for treating homozygous familial...

WellBe Senior Medical Welcomes Dr. Michael Le as New President

CHICAGO, July 8, 2025 /PRNewswire/ -- WellBe Senior Medical has announced the appointment of Dr. Michael Le as the company's first President. Dr. Le brings more than 25 years of leadership experience in both clinical and operational teams within...

Bus crash closes road as car driver trapped

A main road is closed after a crash involving a car and a bus. The incident happened at around 8am on the A4109 Neath Road in Aberdulais. A South Wales Police spokesman said the driver of the car became trapped in the vehicle. A road closure has...

Discover the future of manufacturing at GROB's 5-AXIS LIVE!

Low-intensity focused ultrasound a noninvasive treatment option for lingering COVID symptoms

Low intensity focused ultrasound can significantly improve some of the most common symptoms related to long COVID. A new study conducted by medical tech company Openwater indicates that the noninvasive technique can effectively break down amyloid...

CAR T – cell therapy: The immune system’s smartest weapon yet

Our immune system: Nature’s defense mechanism Our body is capable of self-defense. Whenever we catch an infection, we become normal in the next few days. Many a time this happens without any treatment. The reason being internal immense capacity of...